{"@context":["https://w3id.org/fdo/context/v1",{"schema":"https://schema.org/","prov":"http://www.w3.org/ns/prov#","fdo":"https://w3id.org/fdo/vocabulary/"}],"@id":"https://fdo.portal.mardi4nfdi.de/fdo/Q2013685","@type":"DigitalObject","kernel":{"@id":"https://fdo.portal.mardi4nfdi.de/fdo/Q2013685","digitalObjectType":"https://schema.org/ScholarlyArticle","primaryIdentifier":"mardi:Q2013685","kernelVersion":"v1","immutable":true,"modified":"2026-01-23T16:53:42Z"},"profile":{"@context":"https://schema.org","@type":"ScholarlyArticle","@id":"https://portal.mardi4nfdi.de/entity/Q2013685","name":"On p53 revival using system oriented drug dosage design","headline":"On p53 revival using system oriented drug dosage design","description":"scientific article; zbMATH DE number 6758828","url":"https://portal.mardi4nfdi.de/entity/Q2013685","datePublished":"2017-08-09","author":[{"@id":"https://portal.mardi4nfdi.de/entity/Q2013683"},{"@id":"https://portal.mardi4nfdi.de/entity/Q1642608"},{"@id":"https://portal.mardi4nfdi.de/entity/Q2013684"},{"@id":"https://portal.mardi4nfdi.de/entity/Q1625890"},{"@id":"https://portal.mardi4nfdi.de/entity/Q1642609"},{"@id":"https://portal.mardi4nfdi.de/entity/Q334628"}],"publisher":[{"@id":"https://portal.mardi4nfdi.de/entity/Q69997"}],"identifier":{"@type":"PropertyValue","propertyID":"doi","value":"10.1016/J.JTBI.2016.12.008","url":"https://doi.org/10.1016/J.JTBI.2016.12.008"},"sameAs":["https://doi.org/10.1016/J.JTBI.2016.12.008"],"citation":[{"@id":"https://portal.mardi4nfdi.de/entity/Q1797507"},{"@id":"https://portal.mardi4nfdi.de/entity/Q5403413"}]},"provenance":{"prov:generatedAtTime":"2026-01-23T16:53:42Z","prov:wasAttributedTo":"MaRDI Knowledge Graph"}}